A trial for MyRenalCare found that when patients with chronic kidney disease used the app outpatient capacity was increased, and associated costs decreased.
MyRenalCare app trial increased outpatient capacity by 30%
A trial for MyRenalCare found that when patients with chronic kidney disease used the app outpatient capacity was increased, and associated costs decreased.